BRIEF published on 07/12/2025 at 00:05, 1 year ago BioNxt Solutions propose une offre d'unités d'obligations convertibles Placement Privé Développement De Produits Informations Pour Les Investisseurs Obligation Convertible Solutions BioNxt
PRESS RELEASE published on 07/12/2025 at 00:00, 1 year ago BioNxt Solutions Announces Convertible Debenture Unit Private Placement BioNxt Solutions Inc. announces $1.2M non-brokered private placement of convertible debenture units for product development and commercialization Private Placement Convertible Debentures BioNxt Solutions Inc. Commercialization Product Development
BRIEF published on 07/09/2025 at 03:32, 1 year ago BioNxt Solutions Innovates Targeted Chemotherapy Drug Delivery Precision Oncology Drug Delivery BioNxt Solutions Pharmaceutical Innovations Targeted Chemotherapy
BRIEF published on 07/09/2025 at 03:32, 1 year ago BioNxt Solutions innove dans l'administration ciblée de médicaments de chimiothérapie Oncologie De Précision Solutions BioNxt Administration De Médicaments Innovations Pharmaceutiques Chimiothérapie Ciblée
PRESS RELEASE published on 07/09/2025 at 03:27, 1 year ago BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology BioNxt Solutions Inc. announces breakthrough targeted chemotherapy delivery platform for precision oncology, focusing on tumor-specific drug release and neutralization mechanism Precision Oncology BioNxt Solutions Inc. Drug Delivery Targeted Chemotherapy Chemotherapy Market
BRIEF published on 07/07/2025 at 09:10, 1 year 1 month ago BioNxt Advances Sublingual Cladribine Program for MS Pharmaceutical Development Multiple Sclerosis Treatment BioNxt Solutions Sublingual Cladribine Patient Compliance
BRIEF published on 07/07/2025 at 09:10, 1 year 1 month ago BioNxt fait progresser le programme de cladribine sublinguale pour la sclérose en plaques Développement Pharmaceutique Solutions BioNxt Cladribine Sublinguale Conformité Des Patients Traitement De La Sclérose En Plaques
PRESS RELEASE published on 07/07/2025 at 09:05, 1 year 1 month ago BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase BioNxt Solutions receives cladribine API for BNT23001 sublingual thin-film formulation treating multiple sclerosis. Initiates clinical batch production with European partner Gen-Plus GmbH & Co KG Multiple Sclerosis BioNxt Solutions BNT23001 Cladribine API Sublingual Film
BRIEF published on 06/28/2025 at 01:55, 1 year 1 month ago BioNxt Solutions MCTO Revoked by British Columbia Securities Commission Cease Trade Order Annual Filings Trading Resumption Securities Commission BioNxt Solutions
BRIEF published on 06/28/2025 at 01:55, 1 year 1 month ago La Commission des valeurs mobilières de la Colombie-Britannique a révoqué l'autorisation de mise sur le marché de BioNxt Solutions. Dépôts Annuels Commission Des Valeurs Mobilières Solutions BioNxt Reprise Des Échanges Ordonnance De Cessation D'opérations
Published on 08/07/2026 at 23:15, 22 hours 30 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 22 hours 45 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 23 hours 15 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 23 hours 30 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 5 hours 20 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 22 hours 24 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 2 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 2 hours ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 3 hours ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 1 day 2 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 2 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 3 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 3 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 3 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
